Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
VERI is a precision oncology database created and maintained by The LARVOL Group, LLC. The database is intended for non-commercial use or research in an academic setting, with commercial use requiring a paid license and access to premium content such as news alerts, weekly reports, and conference planners. It enables users to search cancer biomarker evidence by cancer, gene, biomarker, drug, drug class, test, and diagnostics to support evidence-based oncology research.
Parse Score